Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Lumen Technologies | LUMN | Oct 31, 2024 | 6.39 | -4.48 |
Lument Finance Trust | LFT | Oct 31, 2024 | 2.44 | -2.40 |
Lument Finance Trust A Pref | LFT-A | Oct 31, 2024 | 23.00 | 0.00 |
Lumentum | LITE | Oct 31, 2024 | 63.87 | -2.26 |
Luminar Technologies A | LAZR | Oct 31, 2024 | 0.78 | -9.91 |
Lumos Pharma | LUMO | Oct 31, 2024 | 4.44 | +2.30 |
Luna Innovations | LUNA | Oct 31, 2024 | 1.55 | +0.65 |
Luokung Technology | LKCO | Oct 31, 2024 | 1.85 | -2.63 |
Luxfer | LXFR | Oct 31, 2024 | 14.36 | -1.58 |
LuxUrban Hotels | LUXH | Oct 31, 2024 | 0.04 | +13.80 |
Luxurban Hotels Pref | LUXHP | Oct 31, 2024 | 15.75 | +11.86 |
Lxp Industrial Trust | LXP | Oct 31, 2024 | 9.44 | -0.42 |
LXP Industrial Trust C Pref | LXP-C | Oct 31, 2024 | 51.39 | -1.55 |
Lyell Immunopharma | LYEL | Oct 31, 2024 | 0.96 | +11.88 |
Lyft A | LYFT | Oct 31, 2024 | 12.97 | -5.12 |
LyondellBasell Industries Nv A | LYB | Oct 31, 2024 | 86.85 | -0.34 |
Lyra Therapeutics | LYRA | Oct 31, 2024 | 0.27 | +0.84 |
Lytus Technologies | LYT | Oct 31, 2024 | 1.72 | -3.37 |
M&T Bank | MTB | Oct 31, 2024 | 194.68 | -1.46 |
M&T Bank ADR Prej J | MTB-J | Oct 31, 2024 | 27.32 | -0.22 |
M&T Bank H Pref | MTB-H | Oct 31, 2024 | 25.40 | +1.16 |
M-tron Industries | MPTI | Oct 31, 2024 | 50.38 | -3.28 |
M/I Homes | MHO | Oct 31, 2024 | 151.59 | -0.92 |
M3-Brigade Acquisition V | MBAVU | Oct 31, 2024 | 10.09 | 0.00 |
M3-Brigade Acquisition V | MBAV | Oct 31, 2024 | 10.02 | 0.00 |
Macerich | MAC | Oct 31, 2024 | 18.70 | -1.27 |
Mach Natural Resources LP | MNR | Oct 31, 2024 | 16.10 | -0.86 |
MACOM Technology Solutions | MTSI | Oct 31, 2024 | 112.40 | -4.59 |
MacroGenics | MGNX | Oct 31, 2024 | 3.66 | +7.65 |
Macy`s | M | Oct 31, 2024 | 15.34 | -0.58 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.